Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

THEOBID JR.

THEOPHYLLINE

Standard Dose
130MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview THEOBID JR. is listed in Drugs@FDA under application 087854 (ANDA).

Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 130MG Sponsor WHITBY Submission history Latest submission status date: 1985-03-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview THEOBID JR. is listed in Drugs@FDA under application 087854 (ANDA). Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 130MG Sponsor WHITBY Submission history Latest submission status date: 1985-03-20 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.